Dane who died of a blood clot after the AstraZeneca injection had “unusual symptoms”, says the agency

COPENHAGEN (Reuters) – A 60-year-old Danish woman who died of a blood clot after receiving AstraZeneca’s COVID-19 vaccine had “highly unusual” symptoms, according to the Danish Medicines Agency.

The woman had a low number of blood platelets and clots in small and large vessels, as well as bleeding, she said.

Some similar cases have been found in Norway and in the European Medicines Agency (EMA) database of drug side effects, said the Danish Medicines Agency.

“It was an unusual course of illness around death that caused the Danish Medicines Agency to react,” the agency said in a statement late on Sunday.

Norway said on Saturday that three people, all under 50, who received the AstraZeneca vaccine were being treated at the hospital for bleeding, blood clots and a low platelet count, which were labeled “unusual symptoms” by health officials. .

Denmark, Norway and Iceland said last week that they would stop the introduction of the AstraZeneca vaccine.

European vaccination programs have been disrupted in the past two weeks by reports that recipients of the AstraZeneca inoculation have suffered blood clots.

The European Medicines Agency said there was no evidence that the events were caused by vaccination, an opinion that was shared by the World Health Organization on Friday.

AstraZeneca Plc said on Sunday that a review of the safety data of people vaccinated with their COVID-19 vaccine showed no evidence of an increased risk of blood clots.